CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate - Wikidata - wikimedia - TriplyDB

CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate

CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate

http://www.wikidata.org/entity/Q34447710

about

Cancer stem cells (CSCs), cervical CSCs and targeted therapies Prostate epithelial stem and progenitor cells.Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation.High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures Expansion of prostate epithelial progenitor cells after inflammation of the mouse prostate.ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumors Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma.Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft model.The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker.Angiogenic potency evaluation of cell therapy candidates by a novel application of the in vitro aortic ring assay.Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT.Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype.Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.Sphere-Formation Assay: Three-Dimensional Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells

P2860

Q26747144-4AB4EC9C-3BB0-4475-AA6C-A7F71C8B23C9 Q34448228-8172AECF-A4B5-4D55-90B9-84909B7260A9 Q34689170-5AD0D7F5-0E1D-47AC-98B0-5BC4D0A53A12 Q35000400-4E2A1BC0-6BB3-44A3-9E10-CF83A387858B Q35749659-E29D09BB-3FE8-4E31-9D37-752EDFB98536 Q36714784-08253465-7D65-4A14-A8C5-0C65AC1208F7 Q37129032-9870D6FF-A8B5-4A29-BC23-F5A7589B3CE0 Q37582429-C01191A9-8C2B-48D5-8775-3D122CE5EC7B Q39003443-65887FFA-6204-40BA-9D99-E623941F7040 Q39299031-05B1AB8C-1950-4E0B-A0A1-B5417A0F48E4 Q41413714-3F62C930-AB4D-4683-BB60-62213390CB14 Q42154804-94E981CF-ACCE-4A1C-9B5C-02240E3F287A Q42247800-0AC61E42-E19E-409A-99DE-C09279FA5D6C Q42441110-7B12308C-7CDB-47BD-84D7-83022E6CA99E Q42619130-210452DB-4478-420C-90A2-ACD2572E1094 Q47134233-83DAA2AD-7B2F-44DE-BDC7-088350587B0A Q48851514-51D3CE47-6B9F-4287-848D-3B276BF7D749 Q54387640-C5CF1C4A-7296-4923-9B3B-8C637D842AA0 Q58698021-7B99AE00-6D93-481D-86A3-BDCAAFD9AD82

P2860

CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate

http://www.wikidata.org/entity/Q34447710

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

CD49f is an efficient marker o ...... n and malignant human prostate

@ast

CD49f is an efficient marker o ...... n and malignant human prostate

@en

CD49f is an efficient marker o ...... n and malignant human prostate

@nl

type

label

CD49f is an efficient marker o ...... n and malignant human prostate

@ast

CD49f is an efficient marker o ...... n and malignant human prostate

@en

CD49f is an efficient marker o ...... n and malignant human prostate

@nl

prefLabel

CD49f is an efficient marker o ...... n and malignant human prostate

@ast

CD49f is an efficient marker o ...... n and malignant human prostate

@en

CD49f is an efficient marker o ...... n and malignant human prostate

@nl

P1433

Q34447710-4AD35535-18B9-4350-96AB-C384308331D0

P1476

Q34447710-3FA4D02B-0071-47BE-B73B-8FA79539FB06

P2093

Q34447710-0DF309FB-B616-4D00-8543-9325E7C879E5

Q34447710-10CCFFF1-307B-41FB-B513-D2B74096B083

Q34447710-2E8FD6BB-0CE8-4CEC-AC02-53E0F3377038

Q34447710-8BC237EF-D7EA-4D62-A207-C30AB95E6225

Q34447710-A0D2313D-64DD-414E-B1CA-13B479990EBE

P2860

Q34447710-05285DEA-34EA-4454-98B1-C7D6B6156110

Q34447710-0A75FFCD-CC76-4D91-B9B4-1BE7C798ACB6

Q34447710-0AC3AF27-A418-4BE0-9EE3-1AAD586D6033

Q34447710-0AC9EC84-BA8D-4922-ABA2-1D4705BC74B3

Q34447710-14F01CFD-D615-4A54-A8DA-AFEDC249CC13

Q34447710-1D84A1BF-596D-4D52-AA04-4D3903A210CD

Q34447710-1F346B63-ED28-46D8-B0FB-FBD347C34D17

Q34447710-22F15A05-5079-48F1-B762-619AF4AD2926

Q34447710-2386F068-1D9D-4451-9CEE-3108B884327C

Q34447710-259D9608-97AC-4BC7-83B4-F62538890496

P304

Q34447710-8057D046-E7CE-4EB3-93C8-1A4844BD55E0

P31

Q34447710-B599EDDD-892D-4CEA-936E-23225CCAF0F7

P356

Q34447710-5C39FB42-E188-4D50-8863-0382246752D6

P407

Q34447710-75DB9A1B-AD86-419C-BAA8-D39AEA11D730

P433

Q34447710-B6EF3548-D205-4E88-BD79-690EBBBFAD80

P478

Q34447710-D2F9CFE5-5BDC-46AC-B1F8-DDB799387BEC

P50

Q34447710-0CB0840D-4572-46A3-B946-E7AC8D79DE85

Q34447710-CB145913-2896-4418-B515-155D1D9A4BAC

P577

Q34447710-FBE614FD-F431-404B-B06A-4F9777414EFA

P5875

Q34447710-6E0D2522-31AF-46E5-AD0A-2099A5D0B46E

P698

Q34447710-CE963898-2904-40B2-B32C-19CE49A386C2

P932

Q34447710-DDAA27AE-31CD-4DA6-AD8D-5F7B8FA75A61

P356

JOURNAL.PONE.0046979

P1433

P1476

CD49f is an efficient marker o ...... n and malignant human prostate

@en

P2093

Alex Freeman

http://www.w3.org/2001/XMLSchema#string

Ashish Chandra

http://www.w3.org/2001/XMLSchema#string

Hidekazu Yamamoto

http://www.w3.org/2001/XMLSchema#string

John R Masters

http://www.w3.org/2001/XMLSchema#string

Rick Popert

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Identification of a cell of origin for human prostate cancer

The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

Stem cells, cancer, and cancer stem cells

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

P304

e46979

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0046979

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Prokar Dasgupta

P577

2012-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232257318

http://www.w3.org/2001/XMLSchema#string

P698

23071686

http://www.w3.org/2001/XMLSchema#string

P932

3470557

http://www.w3.org/2001/XMLSchema#string